793PDPreliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations
Abida, W, Bryce, A H, Vogelzang, N J, Amato, R J, Percent, I, Shapiro, J D, McDermott, R, Hussain, A, Patnaik, A, Petrylak, D, Ryan, C J, Stanton, T, Zhang, J, Simmons, A D, Despain, D, Collins, M, GoVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy284.002
Date:
October, 2018
File:
PDF, 75 KB
english, 2018